Pharmafile Logo
Pharmafocus logo
Advanced Search
jean-christophe_tellier

UCB names next chief executive

February 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, tellier

Biopharma firm UCB has confirmed its current chief executive Roch Doliveux is to be replaced by Jean-Christophe Tellier. Tellier (pictured) …

Appointment
Yervoy image

NICE restricts Yervoy use

February 25, 2014
Sales and Marketing BMS, Cancer, NHS, NICE, Yervoy, melanoma

Bristol-Myers Squibb has been dealt a blow by NICE after the UK cost watchdog recommended that the use of skin …

News
FDA image

FDA given $20 million for generic testing

February 24, 2014
Manufacturing and Production, Sales and Marketing ADHD, FDA, generics, hamburg

The FDA has been given $20 million to help it assess generic treatments, a group of drugs that makes up …

News

Europe poised for generic Symbicort

February 24, 2014
Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics

The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …

News
GSK image

CHMP breathes new life into GSK, Teva and Novartis

February 24, 2014
Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro

The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …

News
Lisa image

A treatment room view

February 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, Roche, avastin, hinsely

A little more than a year ago, Lisa Hinsley’s prospects were not good. The mother of three had been diagnosed …

Feature

New VP of Operations for Exco InTouch

February 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exco InTouch, burke

Healthcare data services firm Exco InTouch has appointed Laurence Burke as its vice president of Operations. Burke takes over 20 …

Appointment
Gilead image

‘Compassionate’ use of hep C combo

February 24, 2014
Research and Development, Sales and Marketing CHMP, EMA, Gilead, hep C, ledipasvir, sovaldi

A key adviser to the European regulator has said that Gilead Sciences’ fixed-dose combination of Sovaldi and ledipasvir can be …

News
lilly_outside_plaque_1

Lilly drug improves lung cancer survival

February 21, 2014
Research and Development, Sales and Marketing NSCLC, lilly, necitumumab, ramucirumab

News
screen_shot_2014-02-21_at_10

New head of Biosimilars for Merck KGaA

February 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biosimilars, simon sturge

Simon Sturge is joining Merck KGaA from Boehringer Ingelheim in order to head its Biosimilars unit. In his new role …

Appointment
lundbeck_wall_0

Pharma sponsored ‘weekend family gathering’

February 21, 2014
Medical Communications, Sales and Marketing ABPI, Facebook, PMCPA

News
gsk image

GSK/Theravance lung drug bags CHMP approval

February 21, 2014
Sales and Marketing CHMP, COPD, GSK, Theravance, anoro

The CHMP has given its backing to GlaxoSmithKline and partner Theravance’s new chronic obstructive pulmonary disease medicine Anoro. The treatment …

News
allison_jeynes-ellis

Avillion appoints pharma veteran as chief executive

February 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allison Jeynes-Ellis, Avillion

Drug development firm Avillion has appointed Dr Allison Jeynes-Ellis to be its chief executive. By stepping into the role Jeynes-Ellis …

Appointment
Novartis image

Skin cancer pill shows ‘significant’ response

February 20, 2014
Research and Development, Sales and Marketing LDE225, Novartis, bolt, skin cancer, smo

Novartis is celebrating after its investigational pill targeting the most common form of skin cancer met its primary endpoint in …

News

Police raid Novartis Tokyo office

February 20, 2014
Medical Communications, Sales and Marketing Diovan, Japan, Novartis, tokyo

Authorities in Japan have raided the premises of Novartis’ Tokyo operation as part of an ongoing investigation into the promotion …

News
Apple image

Apple files healthcare tech headphones

February 20, 2014
Medical Communications, Sales and Marketing Apple, Samsung, iwatch, technology, wearable

A recently-published Apple patent has shed light on a new health-monitoring device that will be built into a pair of …

News
claes_zackrisson_rsa

RSA appoints director of Information

February 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Claes Zackrisson, rsa

Life sciences executive search and interim management firm RSA has appointed Claes Zackrisson as its first director of information. Zackrisson …

Appointment
Servier image

Servier signs leukaemia deal

February 19, 2014
Research and Development, Sales and Marketing Servier, UCART19, car, cellectis, leaukaemia

French firms Servier and small biopharma cancer specialist Cellectis have signed a deal to develop and commercialise one drug targeting …

News
pradaxa image

Boehringer in hot water over Pradaxa risks

February 19, 2014
Sales and Marketing Boehringer, Pradaxa, Xarelto, dabigatran, lawsuit

Boehringer Ingelheim attempted to delay and revise the publication of important drug information surrounding its new anticoagulant Pradaxa. This is …

News
Biomarin image

Vimizin shown green light

February 19, 2014
Research and Development, Sales and Marketing BioMarin, FDA, congenital enzyme disorder, vimizin

Regulators have shown the green light to BioMarin Pharmaceutical’s Vimizim as a treatment for a rare enzyme deficiency which affects …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026